tiprankstipranks
Crispr Therapeutics AG (GB:0VRQ)
LSE:0VRQ
UK Market

Crispr Therapeutics AG (0VRQ) Technical Analysis

8 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Crispr Therapeutics AG’s (0VRQ) Moving Averages Convergence Divergence (MACD) indicator is -0.11, suggesting Crispr Therapeutics AG is a Buy.
Crispr Therapeutics AG’s (0VRQ) 20-Day exponential moving average is 54.83, while Crispr Therapeutics AG’s (0VRQ) share price is $47.23, making it a Sell.
Crispr Therapeutics AG’s (0VRQ) 50-Day exponential moving average is 54.13, while Crispr Therapeutics AG’s (0VRQ) share price is $47.23, making it a Sell.

Crispr Therapeutics AG (0VRQ) Pivot Points

Sep 15, 2026, 06:27 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
49.61
50.76
51.47
52.62
53.33
54.48
55.19
Fibonacci
50.76
51.47
51.91
52.62
53.33
53.77
54.48
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Crispr Therapeutics AG (0VRQ) Moving Averages

Sep 15, 2026, 06:27 PM
Period
Simple
Exponential
MA5
53.25Sell
53.38Sell
MA10
54.77Sell
54.39Sell
MA20
56.17Sell
54.83Sell
MA50
53.37Sell
54.13Sell
MA100
53.15Sell
53.76Sell
MA200
53.33Sell
54.79Sell
Crispr Therapeutics AG’s (0VRQ) 10-Day exponential moving average is 54.39, while Crispr Therapeutics AG’s (0VRQ) share price is $47.23, making it a Sell.
Crispr Therapeutics AG’s (0VRQ) 100-Day exponential moving average is 53.76, while Crispr Therapeutics AG’s (0VRQ) share price is $47.23, making it a Sell.
Crispr Therapeutics AG’s (0VRQ) stock price is $47.23 and Crispr Therapeutics AG’s (0VRQ) 50-day simple moving average is 53.37, creating a Sell signal.
Crispr Therapeutics AG’s (0VRQ) stock price is $47.23 and Crispr Therapeutics AG’s (0VRQ) 100-day simple moving average is 53.15, creating a Sell signal.
Crispr Therapeutics AG’s (0VRQ) stock price is $47.23 and Crispr Therapeutics AG’s (0VRQ) 200-day simple moving average is 53.33, creating a Sell signal.

Crispr Therapeutics AG (0VRQ) Technical Indicators

Sep 15, 2026, 06:27 PM
Name
Value
Implied Action
RSI (14)
43.66
Neutral
STOCH (9,6)
11.96
Buy
STOCHRSI (14)
9.06
Buy
MACD (12,26)
-0.11
Buy
ADX (14)
24.35
Neutral
Williams %R
-79.89
Buy
CCI (14)
-121.46
Buy
ATR (14)
2.77
-
Ultimate Oscillator
41.20
Neutral
ROC
-7.21
Sell
Crispr Therapeutics AG’s (0VRQ) Relative Strength Index (RSI) is 43.66, creating a Neutral signal.
Crispr Therapeutics AG’s (0VRQ) Trend Strength Indicator (ADX) is 24.35, creating a Neutral signal.
Crispr Therapeutics AG’s (0VRQ) Commodity Channel Index (CCI) is -121.46, creating a Buy signal.
Crispr Therapeutics AG’s (0VRQ) Price Rate of Change (ROC) is -7.21, creating a Sell signal.

FAQ

Is 0VRQ a Buy, Hold, or Sell?
Based on 0VRQ’s technical indicators, 0VRQ is a Sell.
    What is 0VRQ’s RSI (14)?
    0VRQ’s RSI (14) is 43.66, which suggests 0VRQ is a Neutral.
      What is 0VRQ’s MACD?
      0VRQ’s MACD is -0.11, which suggests 0VRQ is a Buy.
        What is 0VRQ’s 5-day moving average?
        0VRQ’s 5-day moving average is 53.25, which suggests 0VRQ is a Sell.
          What is 0VRQ’s 20-day moving average?
          0VRQ 20-day moving average is 56.17, which suggests 0VRQ is a Sell.
            What is 0VRQ’s 50-day moving average?
            0VRQ’s 50-day moving average is 53.37, which suggests 0VRQ is a Sell.
              What is 0VRQ’s 200-day moving average?
              0VRQ’s 200-day moving average is 53.33, which suggests 0VRQ is a Sell.
                What is 0VRQ’s Williams % R (14)?
                0VRQ’s Williams % R (14) is -79.89, which suggests 0VRQ is a Buy.
                  What is 0VRQ’s CCI (14)?
                  0VRQ’s CCI (14) is -121.46, which suggests 0VRQ is a Buy.
                    What is the share price of Crispr Therapeutics AG?